T. Rowe Price Associates’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$517K Buy
122,120
+59,094
+94% +$264K ﹤0.01% 2443
2025
Q4
$238K Buy
63,026
+15,067
+31% +$29.3K ﹤0.01% 2746
2025
Q3
$78K Hold
47,959
﹤0.01% 2964
2025
Q2
$106K Buy
+47,959
New +$73.6K ﹤0.01% 2883
2023
Q2
Sell
-17,100
Closed -$25K 2938
2023
Q1
$25K Hold
17,100
﹤0.01% 2846
2022
Q4
$40K Hold
17,100
﹤0.01% 2835
2022
Q3
$35K Hold
17,100
﹤0.01% 2876
2022
Q2
$38K Hold
17,100
﹤0.01% 2889
2022
Q1
$114K Hold
17,100
﹤0.01% 2828
2021
Q4
$95K Buy
17,100
+6,400
+60% +$48.4K ﹤0.01% 2883
2021
Q3
$98K Sell
10,700
-4,800
-31% -$44.5K ﹤0.01% 2852
2021
Q2
$172K Sell
15,500
-11,600
-43% -$113K ﹤0.01% 2761
2021
Q1
$231K Buy
+27,100
New +$222K ﹤0.01% 2641

Other funds holding SLS